On this week's COVID-19 update, Dr. Bishop discussed what's happening with booster doses for Moderna and J&J and when they might be ready, data on getting COVID vaccines and flu shots at the same time, and the potential for mix-and-match COVID vaccinations.
On this week's COVID-19 update, Dr. Bishop discussed where we are in terms of the Delta variant wave, Pfizer's submission of vaccine data for kids 5 to 11, the timeline for Moderna and J&J boosters, and more.
On this week's COVID-19 update, Dr. Bishop discussed Johnson & Johnson's data for its booster doses, what the CDC's ACIP meeting is all about, adverse effects, and more. Among the questions he answered:
This week's COVID-19 update was almost all about Pfizer boosters. Pfizer and the FDA released data on safety and efficacy numbers for a third dose of the Pfizer vaccine this week, and the FDA will discuss the data in a meeting on Friday, Sept. 17.
On this week's COVID-19 update, Dr. Steven Bishop discussed several topics, including:
On this week's COVID-19 update, Dr. Bishop discussed the CDC's ACIP meeting on boosters and offered several takeaways based on the meeting. He also answered questions on traveling overseas, long-haul symptoms, getting vaccinated, natural immunity, and more.
On this week's COVID-19 updater, Dr. Bishop discussed the initial data on the Johnson & Johnson boosters, the data behind boosters for immunocompromised individuals, why vaccination is strongly recommended at this point, breakthrough infection symptoms, and more.
On this week's COVID-19 Update, Dr. Steven Bishop discussed the recent recommendations for immunocompromised individuals to get an additional shot of Pfizer or Moderna, the transmission of the Delta variant, when the FDA might fully approve the vaccine, if everyone will eventually be advised to get a booster shot, and more.